Coherus Q2 2026 results release
Analysis based on 8 articles · First reported Jul 22, 2026 · Last updated Jul 22, 2026
The announcement is a routine scheduling event with minimal direct market impact. Investors will await the actual results on August 5 for any material changes to the company's financial outlook.
Coherus Oncology, Inc. announced that its second quarter 2026 financial results will be released on August 5, 2026, followed by a conference call and webcast with management to discuss the results and provide a business update. The company is a commercial-stage oncology firm with an approved PD-1 inhibitor, LOQTORZI, and a pipeline of clinical candidates.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard